Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)

NCT03236688 is registered in ClinicalTrials.gov with Exosome Diagnostics, Inc. as lead sponsor.

NCT NCT03236688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03236688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)
Lead sponsor
Exosome Diagnostics, Inc.
Phase
Observational
Overall status
Suspended
Start date
February 29, 2016
Completion date
December 31, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castrate resistant prostate cancer